1) UKPDS
This study revolutionized the treatment of Type 2 Diabetes.
It showed early and aggressive therapy with sulfonylurea drugs, metformin, or insulin significantly improved small vessel disease.
pubmed.ncbi.nlm.nih.gov
This study revolutionized the treatment of Type 2 Diabetes.
It showed early and aggressive therapy with sulfonylurea drugs, metformin, or insulin significantly improved small vessel disease.
pubmed.ncbi.nlm.nih.gov
Why can't you trust this study?
It was funded primarily by Novo-Nordisk, Pfizer, and Bristol-Myers Squibb.
Novo-Nordisk makes insulin.
Pfizer makes glipizide (sulfonylurea)
Bristol-Myers Squibb makes metformin.
These companies made billions selling these drugs.
It was funded primarily by Novo-Nordisk, Pfizer, and Bristol-Myers Squibb.
Novo-Nordisk makes insulin.
Pfizer makes glipizide (sulfonylurea)
Bristol-Myers Squibb makes metformin.
These companies made billions selling these drugs.
If you've ever wondered why drugs are pushed instead of lifestyle changes, this is why.
The studies aren't credible, but they are used to justify the choice to prescribe meds instead of weight loss, exercise, and dietary changes.
The studies aren't credible, but they are used to justify the choice to prescribe meds instead of weight loss, exercise, and dietary changes.
What's the problem?
The Food Pyramid was heavily funded by the Agricultural Industry.
This agency has a dual mandate - promote health and also promote profits for American farmers.
Clearly, the farmers won this battle.
pubmed.ncbi.nlm.nih.gov
The Food Pyramid was heavily funded by the Agricultural Industry.
This agency has a dual mandate - promote health and also promote profits for American farmers.
Clearly, the farmers won this battle.
pubmed.ncbi.nlm.nih.gov
3) Systolic BP Intervention Trial (SPRINT)
This landmark study showed strict blood pressure control had improved outcomes. The data was so convincing, the trial ended early.
Since then the guidelines have changed and recommended lower blood pressure.
clinicaltrials.gov
This landmark study showed strict blood pressure control had improved outcomes. The data was so convincing, the trial ended early.
Since then the guidelines have changed and recommended lower blood pressure.
clinicaltrials.gov
What's the problem?
This was funded by the National Heart, Lung, and Blood Institute (NHLBI). A government agency can be trusted, right?
Wrong.
The head of the NHLBI is Dr. Gary Gibbons. He was a Harvard graduate with close ties to the AHA and Pew Foundation.
This was funded by the National Heart, Lung, and Blood Institute (NHLBI). A government agency can be trusted, right?
Wrong.
The head of the NHLBI is Dr. Gary Gibbons. He was a Harvard graduate with close ties to the AHA and Pew Foundation.
He was also a Robert Wood Johnson Foundation Awardee.
Robert Wood was the founder of Johnson and Johnson.
Johnson and Johnson earn billions on blood pressure medications through their pharmaceutical branch Janssen.
rwjf.org
Robert Wood was the founder of Johnson and Johnson.
Johnson and Johnson earn billions on blood pressure medications through their pharmaceutical branch Janssen.
rwjf.org
The man sitting at the head of this government agency setting management guidelines has deep ties to the pharmaceutical company set to make billions in profit from his decisions.
Smells fishy.
Smells fishy.
4) High Intensity Statins
This landmark study found:
"intensive lipid-lowering statin regimen provides greater protection against death or major cardiovascular events than does a standard regimen"
This study drove millions of statin prescriptions.
pubmed.ncbi.nlm.nih.gov
This landmark study found:
"intensive lipid-lowering statin regimen provides greater protection against death or major cardiovascular events than does a standard regimen"
This study drove millions of statin prescriptions.
pubmed.ncbi.nlm.nih.gov
What's wrong here?
The study was funded by Bristol-Myers Squibb and Sankyo. The author received speaking fees from Bristol-Myers and Novartis.
Sankyo and Novartis make antihypertensives. Bristol-Myers makes blood thinners.
All 3 companies profit from tighter recommendations.
The study was funded by Bristol-Myers Squibb and Sankyo. The author received speaking fees from Bristol-Myers and Novartis.
Sankyo and Novartis make antihypertensives. Bristol-Myers makes blood thinners.
All 3 companies profit from tighter recommendations.
It's well-known that the funding source can bias the outcomes of clinical trials - even when the funding source is the government.
Here are some examples:
pubmed.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
Here are some examples:
pubmed.ncbi.nlm.nih.gov
pubmed.ncbi.nlm.nih.gov
As the old saying goes, "follow the money"
If a pharmaceutical company is funding a study, they are looking for a result. With enough time and data manipulation, they'll find it.
Approach these studies cautiously and don't fall for the scam.
If a pharmaceutical company is funding a study, they are looking for a result. With enough time and data manipulation, they'll find it.
Approach these studies cautiously and don't fall for the scam.
If you learned something from this thread, you'll enjoy my substack.
Docanarchy.substack.com
Docanarchy.substack.com
Loading suggestions...